BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 29794466)

  • 1. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
    Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FOXK1-CCDC43 Axis Promotes the Invasion and Metastasis of Colorectal Cancer Cells.
    Wang J; Liu G; Liu M; Xiang L; Xiao Y; Zhu H; Wu X; Peng Y; Zhang W; Jiang P; Li A; Nan Q; Chen Y; Chen C; Cheng T; Liu S; Wang J
    Cell Physiol Biochem; 2018; 51(6):2547-2563. PubMed ID: 30562730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
    Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
    Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
    Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUFY3 interaction with FOXK1 promotes invasion and metastasis in colorectal cancer.
    Xie R; Wang J; Liu X; Wu L; Zhang H; Tang W; Li Y; Xiang L; Peng Y; Huang X; Bai Y; Liu G; Li A; Wang Y; Chen Y; Ren Y; Li G; Gong W; Liu S; Wang J
    Sci Rep; 2017 Jun; 7(1):3709. PubMed ID: 28623323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
    Zhang Z; Zhang W; Mao J; Xu Z; Fan M
    Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
    Wang G; Gu J; Gao Y
    Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism.
    Yang J; Zhang K; Song H; Wu M; Li J; Yong Z; Jiang S; Kuang X; Zhang T
    Oncotarget; 2016 May; 7(22):32306-17. PubMed ID: 27058759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
    Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
    Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells.
    Peng Y; Zhang P; Huang X; Yan Q; Wu M; Xie R; Wu Y; Zhang M; Nan Q; Zhao J; Li A; Xiong J; Ren Y; Bai Y; Chen Y; Liu S; Wang J
    Cell Death Dis; 2016 Nov; 7(11):e2480. PubMed ID: 27882939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting Forkhead box K1 induces autophagy to reverse epithelial-mesenchymal transition and metastasis in gastric cancer by regulating Myc-associated zinc finger protein in an acidic microenvironment.
    Wang Y; Sun L; Qiu W; Qi W; Qi Y; Liu Z; Liu S; Lv J
    Aging (Albany NY); 2020 Apr; 12(7):6129-6150. PubMed ID: 32268297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.
    Zhao GX; Xu YY; Weng SQ; Zhang S; Chen Y; Shen XZ; Dong L; Chen S
    Oncogene; 2019 Jun; 38(23):4574-4589. PubMed ID: 30742066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1.
    Wang S; Yan S; Zhu S; Zhao Y; Yan J; Xiao Z; Bi J; Qiu J; Zhang D; Hong Z; Zhang L; Huang C; Li T; Liang L; Liao W; Jiao H; Ding Y; Ye Y
    Neoplasia; 2018 Oct; 20(10):996-1007. PubMed ID: 30189360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
    Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
    Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 19. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
    Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD
    Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant activation of CYR61 enhancers in colorectal cancer development.
    Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
    J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.